Lack of causal association between heart failure and osteoporosis: a Mendelian randomization study

BMC Med Genomics. 2022 Nov 4;15(1):232. doi: 10.1186/s12920-022-01385-8.

Abstract

Objectives: Heart failure (HF) has been implicated in osteoporosis. However, causality remains unestablished. Here, we sought to assess causal associations of genetic liability to HF with osteoporosis using Mendelian randomization (MR) analyses.

Methods: Independent single nucleotide polymorphisms associated with HF at genome-wide significance were derived from a large genome-wide association study (GWAS) (including up to 977,323 individuals). We obtained summary statistics for forearm (FA) bone mineral density (BMD) (n = 8,143), femoral neck (FN) BMD (n = 32,735), lumbar spine (LS) BMD (n = 28,498), heel (HE) BMD (n = 426,824), and fracture (n = 1,214,434) from other GWAS meta-analyses. Inverse variance weighted (IVW) and several supplementary methods were performed to calculate the MR estimates.

Results: Genetically determined HF has no causal effect on FA-BMD (odds ratio (OR) 1.17; 95% confidence interval (CI) 0.82, 1.66; P = 0.389), FN-BMD (OR 1.01; 95% CI 0.85, 1.19; P = 0.936), LS-BMD (OR 0.96; 95% CI 0.80, 1.17; P = 0.705), HE-BMD (OR 1.01; 95% CI 0.90, 1.13; P = 0.884), and fracture risk (OR 1.00; 95% CI 0.92, 1.10; P = 0.927). Complementary analyses returned broadly consistent results.

Conclusion: This MR study provides genetic evidence that HF may not lead to an increased risk of reduced BMDs or fracture.

Keywords: Bone mineral density; Causal association; Fracture; Heart failure; Mendelian randomization; Osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Density / genetics
  • Genome-Wide Association Study
  • Heart Failure* / genetics
  • Humans
  • Mendelian Randomization Analysis / methods
  • Osteoporosis* / genetics
  • Polymorphism, Single Nucleotide